BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38873576)

  • 1. Association of calciprotein particles with serum phosphorus among patients undergoing conventional and extended-hours haemodialysis.
    Nishibori N; Okazaki M; Miura Y; Hishida M; Kurasawa S; Imaizumi T; Kato N; Kosugi T; Kuro-O M; Kasuga H; Kaneda F; Maruyama S
    Clin Kidney J; 2024 Jun; 17(6):sfae121. PubMed ID: 38873576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of Serum Calciprotein Particle Size and Transformation Time With Arterial Calcification, Arterial Stiffness, and Mortality in Incident Hemodialysis Patients.
    Chen W; Fitzpatrick J; Monroy-Trujillo JM; Sozio SM; Jaar BG; Estrella MM; Serrano J; Anokhina V; Miller BL; Melamed ML; Bushinsky DA; Parekh RS
    Am J Kidney Dis; 2021 Mar; 77(3):346-354. PubMed ID: 32800846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Sevelamer on Calciprotein Particles in Hemodialysis Patients: The Sevelamer Versus Calcium to Reduce Fetuin-A-Containing Calciprotein Particles in Dialysis (SCaRF) Randomized Controlled Trial.
    Smith ER; Pan FFM; Hewitson TD; Toussaint ND; Holt SG
    Kidney Int Rep; 2020 Sep; 5(9):1432-1447. PubMed ID: 32954068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lanthanum carbonate on serum calciprotein particles in patients with stage 3-4 CKD-results from a placebo-controlled randomized trial.
    Tiong MK; Smith ER; Pascoe EM; Elder GJ; Lioufas NM; Pedagogos E; Hawley CM; Valks A; Holt SG; Hewitson TD; Toussaint ND
    Nephrol Dial Transplant; 2023 Feb; 38(2):344-351. PubMed ID: 35212735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells.
    Thiem U; Hewitson TD; Toussaint ND; Holt SG; Haller MC; Pasch A; Cejka D; Smith ER
    Nephrol Dial Transplant; 2023 May; 38(5):1282-1296. PubMed ID: 36107466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of lanthanum carbonate on calciprotein particles in hemodialysis patients.
    Nakamura K; Nagata Y; Hiroyoshi T; Isoyama N; Fujikawa K; Miura Y; Matsuyama H; Kuro-O M
    Clin Exp Nephrol; 2020 Apr; 24(4):323-329. PubMed ID: 31875935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Flux Hemodialysis and High-Volume Hemodiafiltration Improve Serum Calcification Propensity.
    Dekker M; Pasch A; van der Sande F; Konings C; Bachtler M; Dionisi M; Meier M; Kooman J; Canaud B
    PLoS One; 2016; 11(4):e0151508. PubMed ID: 27064679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects for inflammatory responses by CPP with different colloidal properties in hemodialysis patients.
    Mukai H; Miura Y; Kotani K; Kotoda A; Kurosu H; Yamada T; Kuro-O M; Iwazu Y
    Sci Rep; 2022 Dec; 12(1):21856. PubMed ID: 36528732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineral bone disorder and its management among hemodialysis patients in the Gulf Cooperation Council: Initial findings from the dialysis outcomes and practice patterns study (2012-2015).
    Al Salmi I; AlRukhaimi M; AlSahow A; Shaheen FA; Al-Ghamdi SM; AlAli F; AlGhareeb S; Al Maimani Y; AlGhonaim M; Bieber B; Tentori F; Pisoni RL;
    Saudi J Kidney Dis Transpl; 2016 Nov; 27(6 Suppl 1):62-80. PubMed ID: 27991480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calciprotein Particles Induce Endothelial Dysfunction by Impairing Endothelial Nitric Oxide Metabolism.
    Feenstra L; Kutikhin AG; Shishkova DK; Buikema H; Zeper LW; Bourgonje AR; Krenning G; Hillebrands JL
    Arterioscler Thromb Vasc Biol; 2023 Mar; 43(3):443-455. PubMed ID: 36727521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of increasing dialysate magnesium on calciprotein particles, inflammation and bone markers: post hoc analysis from a randomized controlled clinical trial.
    Bressendorff I; Hansen D; Pasch A; Holt SG; Schou M; Brandi L; Smith ER
    Nephrol Dial Transplant; 2021 Mar; 36(4):713-721. PubMed ID: 31764984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of calciprotein particles measured by a new method with coronary artery plaque in patients with coronary artery disease: A cross-sectional study.
    Nakazato J; Hoshide S; Wake M; Miura Y; Kuro-O M; Kario K
    J Cardiol; 2019 Nov; 74(5):428-435. PubMed ID: 31101573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.
    Copland M; Komenda P; Weinhandl ED; McCullough PA; Morfin JA
    Am J Kidney Dis; 2016 Nov; 68(5S1):S24-S32. PubMed ID: 27772640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with Fabry disease.
    Bruell S; Nicholls KM; Hewitson TD; Talbot AS; Holt SG; Smith ER; Ruderman I
    Osteoporos Int; 2022 Aug; 33(8):1783-1794. PubMed ID: 35575807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study.
    Zhan Z; Smyth B; Toussaint ND; Gray NA; Zuo L; de Zoysa JR; Chan CT; Jin C; Scaria A; Hawley CM; Perkovic V; Jardine MJ; Zhang L
    BMC Nephrol; 2019 Jul; 20(1):258. PubMed ID: 31299919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mid-term predictive value of calciprotein particles in maintenance hemodialysis patients based on a gel-filtration assay.
    Gatate Y; Nakano S; Mizuno Y; Muramatsu T; Senbonmatsu T; Nishimura S; Kono R; Kaneko K; Miura Y; Kuro-O M
    Atherosclerosis; 2020 Jun; 303():46-52. PubMed ID: 32307113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of graft and patient outcomes following kidney transplantation in extended hour and conventional haemodialysis patients.
    See EJ; Hawley CM; Cho Y; Toussaint ND; Agar JW; Pascoe EM; Lim WH; Francis RS; Collins MG; Johnson DW
    Nephrology (Carlton); 2019 Jan; 24(1):111-120. PubMed ID: 29316017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetuin-A-containing calciprotein particle levels can be reduced by dialysis, sodium thiosulphate and plasma exchange. Potential therapeutic implications for calciphylaxis?
    Cai MM; Smith ER; Brumby C; McMahon LP; Holt SG
    Nephrology (Carlton); 2013 Nov; 18(11):724-7. PubMed ID: 24571743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD.
    Smith ER; Ford ML; Tomlinson LA; Rajkumar C; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2012 May; 27(5):1957-66. PubMed ID: 22105144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary calciprotein particle size is associated with patient mortality in peripheral artery disease.
    Bojic M; Cejka D; Bielesz B; Schernthaner GH; Höbaus C
    Atherosclerosis; 2023 Apr; 370():12-17. PubMed ID: 36898866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.